Drug Patents owned by Protega Pharms

1. List of Roxybond drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7955619 PROTEGA PHARMS Abuse resistant drugs, method of use and method of making
Aug, 2028

(5 years from now)

US10314788 PROTEGA PHARMS Pharmaceutical compositions configured to deter dosage form splitting
Aug, 2028

(5 years from now)

Drugs and Companies using OXYCODONE HYDROCHLORIDE ingredient

Market Authorisation Date: 20 April, 2017

Treatment: NA


More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in